Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use ARIPIPRAZOLE ORALLY DISINTEGRATING TABLETS safely and effectively. See full prescribing information for ARIPIPRAZOLE ORALLY DISINTEGRATING TABLETS. ARIPIPRAZOLE orally disintegrating tablets Initial U.S. Approval: 2002
Medication labelWhy this: Advisory · dailymed-prescription
Aripiprazole orally disintegrating tablets are indicated for the treatment of: Schizophrenia [see Clinical Studies (14.1)] Acute Treatment of Manic and Mixed Episodes associated with Bipolar I Disorder [see Clinical Studies (14.2)] Adjunctive Treatment of Major Depressive Disorder [see Clinical Studies (14.3)] Irritability Associated with Autistic Disorder [see Clinical Studies (14.4)] Treatment of Tourette’s Disorder [see Clinical Studies (14.5)]
- generic_name
- aripiprazole orally disintegrating
- product_names
- Aripiprazole orally disintegrating
- ndc
- 43598-733, 43598-734, 43598-733-30, 43598-734-30
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en